UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects

British journal of clinical pharmacology, 2013-11, Vol.76 (5), p.776-786

2013

Volltextzugriff (PDF)

Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects

British journal of clinical pharmacology, 2013-02, Vol.75 (2), p.476-487

2013

Volltextzugriff (PDF)

Evaluation of the absolute oral bioavailability of the anaplastic lymphoma kinase/c-ROS oncogene 1 kinase inhibitor lorlatinib in healthy participants

Cancer chemotherapy and pharmacology, 2022-01, Vol.89 (1), p.71-81

2022

Volltextzugriff (PDF)

The effect of itraconazole on the pharmacokinetics of lorlatinib: results of a phase I, open-label, crossover study in healthy participants

Investigational new drugs, 2020-02, Vol.38 (1), p.131-139

2020

Volltextzugriff (PDF)

Determining spatial units for modeling regional nonnative invasive plant species spread in the southern US forestlands: using the state of Alabama as an example

Forestry research (Fayetteville, Ga.), 2024-01, Vol.4 (1), p.1-10

2024

Volltextzugriff (PDF)

A meta-analytical review of the effects of environmental and ecological drivers on the abundance of red snapper (Lutjanus campechanus) in the U.S. Gulf of Mexico

Reviews in fish biology and fisheries, 2020-09, Vol.30 (3), p.437-462

2020

Volltextzugriff (PDF)

Impact of Disturbances on Species Diversity and Regeneration of Nepalese Sal (Shorea robusta) Forests Managed under Different Management Regimes

Earth (Basel, Switzerland), 2021-12, Vol.2 (4), p.826-844

2021

Volltextzugriff (PDF)

An Open-label, Single-Dose, Pharmacokinetic Study of Factor VIII Activity After Administration of Moroctocog Alfa (AF-CC) in Male Chinese Patients With Hemophilia A

Clinical therapeutics, 2017-07, Vol.39 (7), p.1313-1319

2017

Volltextzugriff (PDF)

Spatiotemporal Invasion Severity of Chinese Tallow (Triadica sebifera) and Invasibility of Forest Types in Southern US Forestlands

Forest science, 2021-10, Vol.67 (5), p.491-500

2021

Volltextzugriff (PDF)

Developing a Multiscale Modeling Framework to Assess Forest Health Risk Based on the FIA Data

Nepal, Sunil

2022

Volltextzugriff (PDF)

Regional Gastrointestinal Absorption of Apixaban in Healthy Subjects

Journal of clinical pharmacology, 2018-07, Vol.58 (7), p.965-971

2018

Volltextzugriff (PDF)

Modeling spatial variations of the invasibility of slash pine flatwoods to Chinese tallow (Triadica sebifera) invasion: Mechanisms and key factors at the microscale

Forest ecology and management, 2021-02, Vol.482, p.118798, Article 118798

2021

Volltextzugriff (PDF)

Correction to: Evaluation of the absolute oral bioavailability of the anaplastic lymphoma kinase/c-ROS oncogene 1 kinase inhibitor lorlatinib in healthy participants

Cancer chemotherapy and pharmacology, 2022-06, Vol.89 (6), p.839-839

2022

Volltextzugriff (PDF)

Comparative nutritional value of Jatropha curcas protein isolate and soy protein isolate in common carp

Fish physiology and biochemistry, 2018-02, Vol.44 (1), p.143-162

2018

Volltextzugriff (PDF)

Phase 1 Study Evaluating the Effects of the Proton Pump Inhibitor Rabeprazole and Food on the Pharmacokinetics of Lorlatinib in Healthy Participants

Clinical pharmacology in drug development, 2021-11, Vol.10 (11), p.1395-1404

2021

Volltextzugriff (PDF)

Lack of an Effect of Supratherapeutic Dose of Venlafaxine on Cardiac Repolarization in Healthy Subjects

Clinical pharmacology in drug development, 2022-01, Vol.11 (1), p.100-111

2022

Volltextzugriff (PDF)

Randomized, blinded, placebo- and positive-controlled crossover study to determine the effect of multiple doses of apixaban on the QTc interval

Journal of clinical pharmacology, 2015-05, Vol.55 (5), p.549-555

2015

Volltextzugriff (PDF)

Evaluating economic impacts of different silvicultural approaches in bottomland hardwood forests of the Lower Mississippi Alluvial Valley (LMAV)

Nepal, Sunil

2016

Volltextzugriff (PDF)

No Clinical Impact of CYP3A5 Gene Polymorphisms on the Pharmacokinetics and/or Efficacy of Maraviroc in Healthy Volunteers and HIV‐1–Infected Subjects

Journal of clinical pharmacology, 2019-01, Vol.59 (1), p.139-152

2019

Volltextzugriff (PDF)

Apixaban, an oral, direct factor X a inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects

British journal of clinical pharmacology, 2013-02, Vol.75 (2), p.476-487

2013

Volltextzugriff (PDF)

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor X a inhibitor, in healthy subjects

British journal of clinical pharmacology, 2013-11, Vol.76 (5), p.776-786

2013

Volltextzugriff (PDF)

Lack of Drug Interaction between Metformin and Muraglitazar, a Novel Dual PPAR [alpha]/[gamma] Agonist under Investigation for the Treatment of Type 2 Diabetes

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A509

2005

Volltextzugriff (PDF)

Lack of Pharmacokinetic Interaction between Glyburide and the Novel Dual PPAR [alpha]/[gamma] Agonist Muraglitazar

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A509

2005

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(52)

Publikationsform

Sprache

Englisch
(60)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects

Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects

Evaluation of the absolute oral bioavailability of the anaplastic lymphoma kinase/c-ROS oncogene 1 kinase inhibitor lorlatinib in healthy participants

The effect of itraconazole on the pharmacokinetics of lorlatinib: results of a phase I, open-label, crossover study in healthy participants

Determining spatial units for modeling regional nonnative invasive plant species spread in the southern US forestlands: using the state of Alabama as an example

A meta-analytical review of the effects of environmental and ecological drivers on the abundance of red snapper (Lutjanus campechanus) in the U.S. Gulf of Mexico

Impact of Disturbances on Species Diversity and Regeneration of Nepalese Sal (Shorea robusta) Forests Managed under Different Management Regimes

An Open-label, Single-Dose, Pharmacokinetic Study of Factor VIII Activity After Administration of Moroctocog Alfa (AF-CC) in Male Chinese Patients With Hemophilia A

Spatiotemporal Invasion Severity of Chinese Tallow (Triadica sebifera) and Invasibility of Forest Types in Southern US Forestlands

Developing a Multiscale Modeling Framework to Assess Forest Health Risk Based on the FIA Data

Regional Gastrointestinal Absorption of Apixaban in Healthy Subjects

Modeling spatial variations of the invasibility of slash pine flatwoods to Chinese tallow (Triadica sebifera) invasion: Mechanisms and key factors at the microscale

Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation

Correction to: Evaluation of the absolute oral bioavailability of the anaplastic lymphoma kinase/c-ROS oncogene 1 kinase inhibitor lorlatinib in healthy participants

Comparative nutritional value of Jatropha curcas protein isolate and soy protein isolate in common carp

Phase 1 Study Evaluating the Effects of the Proton Pump Inhibitor Rabeprazole and Food on the Pharmacokinetics of Lorlatinib in Healthy Participants

Lack of an Effect of Supratherapeutic Dose of Venlafaxine on Cardiac Repolarization in Healthy Subjects

Randomized, blinded, placebo- and positive-controlled crossover study to determine the effect of multiple doses of apixaban on the QTc interval

Evaluating economic impacts of different silvicultural approaches in bottomland hardwood forests of the Lower Mississippi Alluvial Valley (LMAV)

No Clinical Impact of CYP3A5 Gene Polymorphisms on the Pharmacokinetics and/or Efficacy of Maraviroc in Healthy Volunteers and HIV‐1–Infected Subjects

Apixaban, an oral, direct factor X a inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor X a inhibitor, in healthy subjects

Response to Letter Regarding Article, “Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation”

Lack of Drug Interaction between Metformin and Muraglitazar, a Novel Dual PPAR [alpha]/[gamma] Agonist under Investigation for the Treatment of Type 2 Diabetes

Lack of Pharmacokinetic Interaction between Glyburide and the Novel Dual PPAR [alpha]/[gamma] Agonist Muraglitazar

Suchergebnisse filtern